anthracene has been researched along with biotin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Raska, I; Toropov, AA; Toropova, AP | 1 |
| Fiammengo, R; Ge, B; Helm, M; Jäschke, A; Petermeier, M | 1 |
| Arya, M; Kaithwas, G; Kanoujia, J; Parashar, P; Saraf, SA; Singh, M; Tripathi, CB | 1 |
3 other study(ies) available for anthracene and biotin
| Article | Year |
|---|---|
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
Topics: Models, Molecular; Models, Statistical; Molecular Structure; Octanols; Quantitative Structure-Activity Relationship; Vitamins; Water | 2008 |
Allosterically activated Diels-Alder catalysis by a ribozyme.
Topics: Anthracenes; Base Sequence; Biotin; Catalysis; DNA-Directed RNA Polymerases; Kinetics; Maleimides; Molecular Sequence Data; Nucleic Acid Conformation; Nucleotides; RNA; RNA, Catalytic; Theophylline; Viral Proteins | 2005 |
Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Biotin; Breast Neoplasms; Cardiotoxicity; Delayed-Action Preparations; Doxorubicin; Drug Compounding; Drug Liberation; Fatty Acids; Female; Humans; Liposomes; MCF-7 Cells; Mitochondrial Membranes; Molecular Targeted Therapy; Nanostructures; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Reactive Oxygen Species; Surface Properties; Tissue Distribution; Tumor Microenvironment | 2020 |